POINT Biopharma Global

POINT Biopharma is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for treating cancer. In addition to our exciting pipeline of radioligand molecules for various cancers, we also operate our radiopharmaceutical manufacturing facility in Indiana, which is capable of serving all of North America as well as many regions worldwide.